The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Hsu(Baylor College of Medicine), Lukas M. Simon(Baylor College of Medicine), Nicholas J. Neill(Baylor College of Medicine), Richard Marcotte(University Health Network), Azin Sayad(University Health Network), Christopher S. Bland(Baylor College of Medicine), Gloria V. Echeverria(Baylor College of Medicine), Tingting Sun(Baylor College of Medicine), Sarah J. Kurley(Baylor College of Medicine), Siddhartha Tyagi(Baylor College of Medicine), Kristen L. Karlin(Baylor College of Medicine), Rocío Domínguez-Vidaña(Baylor College of Medicine), Jessica D. Hartman(Baylor College of Medicine), Alexander Renwick(Baylor College of Medicine), Kathleen A. Scorsone(Baylor College of Medicine), Ronald J. Bernardi(Baylor College of Medicine), Samuel O. Skinner(University of Illinois Urbana-Champaign), Antrix Jain(Baylor College of Medicine), Mayra Orellana(Baylor College of Medicine), Chandraiah Lagisetti(SRI International), Ido Golding(University of Illinois Urbana-Champaign), Sung Yun Jung(Baylor College of Medicine), Joel R. Neilson(Baylor College of Medicine), Xiang H.-F. Zhang(Baylor College of Medicine), Thomas A. Cooper(Baylor College of Medicine), Thomas R. Webb(SRI International), Benjamin G. Neel(University Health Network), Chad A. Shaw(Baylor College of Medicine), Thomas F. Westbrook(Baylor College of Medicine)
Cited by 522Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis